Histogen to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, announced its participation in the H.C. Wainwright Global Life Sciences Virtual Conference. The presentation will be available for on-demand listening starting March 9, 2021, at 7:00 AM Eastern Time. Histogen focuses on developing innovative restorative therapeutics that harness the body's natural repair mechanisms. Their technology platform features cell conditioned media and extracellular matrix materials for various therapeutic applications, including hair growth and joint regeneration.

SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced it will present at the H.C. Wainwright Global Life Sciences Virtual Conference.

The presentation will be available for on-demand listening beginning Tuesday, March 9, 2021 at 7:00 AM Eastern Time and can be accessed using the link https://journey.ct.events/view/7966236d-e7ae-450b-b02f-b0720cfcf78a.

About Histogen
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When will Histogen Inc. present at the H.C. Wainwright Global Life Sciences Virtual Conference?

Histogen Inc. will present at the H.C. Wainwright Global Life Sciences Virtual Conference starting March 9, 2021, at 7:00 AM Eastern Time.

What is the focus of Histogen Inc.'s therapeutic development?

Histogen Inc. focuses on developing first-in-class restorative therapeutics that stimulate the body's natural repair processes.

How can I access Histogen Inc.'s presentation from the conference?

The presentation can be accessed on-demand via the link provided by Histogen Inc. starting March 9, 2021.

What innovative technologies does Histogen Inc. utilize?

Histogen Inc. utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells.

What therapeutic applications does Histogen Inc.'s technology target?

Histogen Inc.'s technology targets applications such as hair growth, dermal rejuvenation, joint cartilage regeneration, and spinal disk repair.